Observe Medical ASA: Mandatory notification of trade

Oslo, 7 January 2025

Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 7 January 2025 regarding the approval by the extraordinary general meeting of a share capital increase of NOK 1.30 through the issue of 5 new shares, each with a nominal value of NOK 0.26, in connection with the resolved share consolidation of the Company's shares.

Ingerø Reiten Investment Company AS has subscribed for 5 new shares in the Company in said share capital increase. Ingerø Reiten Investment Company AS is represented on the Company's board of directors by Terje Bakken (chairperson).

Please see the attached notification form for further information.

This information is subject to the disclosure requirements pursuant to article 19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.